Black Hawk Acquisition Corp
BKHAAnalytical Summary
Black Hawk Acquisition Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
12-Year Financial Trajectory
QuarterlyBullish Indicators
- No bullish signals detected.
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q2 FY2026 May 31, 2026 10-Q ↗ | Q1 FY2026 Feb 28, 2026 10-Q ↗ | Q4 FY2025 Nov 30, 2025 10-K ↗ | Q3 FY2025 Aug 31, 2025 10-Q ↗ | Q2 FY2025 May 31, 2025 10-Q ↗ | Q1 FY2025 Feb 28, 2025 10-Q ↗ | Q4 FY2024 Nov 30, 2024 10-K ↗ | Q3 FY2024 Aug 31, 2024 10-Q ↗ | Q2 FY2024 May 31, 2024 10-Q ↗ | Q1 FY2024 Feb 29, 2024 10-Q ↗ | Q4 FY2023 Nov 30, 2023 10-K ↗ | Q2 FY2023 May 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Growth YoY (%) |
-82.9%
Weak
→
Weak
Stable
Year-over-year change in net income |
-78.8%
Weak
↓
Weak
Declining
Year-over-year change in net income |
N/M |
-82.5%
Weak
Weak
Year-over-year change in net income |
67.4%
Excellent
Excellent
Year-over-year change in net income |
N/M | — | — | — | — | — | — |
| Metric | Q2 FY2026 May 31, 2026 10-Q ↗ | Q1 FY2026 Feb 28, 2026 10-Q ↗ | Q4 FY2025 Nov 30, 2025 10-K ↗ | Q3 FY2025 Aug 31, 2025 10-Q ↗ | Q2 FY2025 May 31, 2025 10-Q ↗ | Q1 FY2025 Feb 28, 2025 10-Q ↗ | Q4 FY2024 Nov 30, 2024 10-K ↗ | Q3 FY2024 Aug 31, 2024 10-Q ↗ | Q2 FY2024 May 31, 2024 10-Q ↗ | Q1 FY2024 Feb 29, 2024 10-Q ↗ | Q4 FY2023 Nov 30, 2023 10-K ↗ | Q2 FY2023 May 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-2.66x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.78x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
26.69x
Excellent
↑
Excellent
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.70x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
-0.25x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.08x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
1.23x
Good
Good
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | Q2 FY2026 May 31, 2026 10-Q ↗ | Q1 FY2026 Feb 28, 2026 10-Q ↗ | Q4 FY2025 Nov 30, 2025 10-K ↗ | Q3 FY2025 Aug 31, 2025 10-Q ↗ | Q2 FY2025 May 31, 2025 10-Q ↗ | Q1 FY2025 Feb 28, 2025 10-Q ↗ | Q4 FY2024 Nov 30, 2024 10-K ↗ | Q3 FY2024 Aug 31, 2024 10-Q ↗ | Q2 FY2024 May 31, 2024 10-Q ↗ | Q1 FY2024 Feb 29, 2024 10-Q ↗ | Q4 FY2023 Nov 30, 2023 10-K ↗ | Q2 FY2023 May 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) |
1.7%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
0.9%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
4.5%
Caution
↓
Caution
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
8.1%
Fair
↑
Fair
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
7.7%
Fair
↑
Fair
Improving
Return earned on debt + equity capital invested
Optimal:
> 10%
|
3.8%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
3.7%
Weak
↓
Weak
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
3.2%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
14.3%
Good
Good
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — |
| Return on Capital (%) (%) |
-0.4%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-0.2%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-0.9%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-1.5%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-0.3%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-0.1%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-0.1%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-0.1%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
-0.5%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — |
| Return on Common Equity (%) (%) |
-1.7%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-112%)
|
-3.1%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-121%)
|
0.1%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-99%)
|
-4.7%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-131%)
|
-20.6%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-237%)
|
-28.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-293%)
|
-34.6%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-331%)
|
-42.6%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-384%)
|
-15.6%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-204%)
|
125.0%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+734%)
|
— | — |
| Metric | Q2 FY2026 May 31, 2026 10-Q ↗ | Q1 FY2026 Feb 28, 2026 10-Q ↗ | Q4 FY2025 Nov 30, 2025 10-K ↗ | Q3 FY2025 Aug 31, 2025 10-Q ↗ | Q2 FY2025 May 31, 2025 10-Q ↗ | Q1 FY2025 Feb 28, 2025 10-Q ↗ | Q4 FY2024 Nov 30, 2024 10-K ↗ | Q3 FY2024 Aug 31, 2024 10-Q ↗ | Q2 FY2024 May 31, 2024 10-Q ↗ | Q1 FY2024 Feb 29, 2024 10-Q ↗ | Q4 FY2023 Nov 30, 2023 10-K ↗ | Q2 FY2023 May 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Coverage (x) |
-4.48x
Weak
↑
Weak
Improving
Operating income divided by interest expense
Optimal:
> 5x
|
-2.79x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— |
-105.20x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — | — | — | — | — | — | — |
| Net Debt (USD) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Metric | Q2 FY2026 May 31, 2026 10-Q ↗ | Q1 FY2026 Feb 28, 2026 10-Q ↗ | Q4 FY2025 Nov 30, 2025 10-K ↗ | Q3 FY2025 Aug 31, 2025 10-Q ↗ | Q2 FY2025 May 31, 2025 10-Q ↗ | Q1 FY2025 Feb 28, 2025 10-Q ↗ | Q4 FY2024 Nov 30, 2024 10-K ↗ | Q3 FY2024 Aug 31, 2024 10-Q ↗ | Q2 FY2024 May 31, 2024 10-Q ↗ | Q1 FY2024 Feb 29, 2024 10-Q ↗ | Q4 FY2023 Nov 30, 2023 10-K ↗ | Q2 FY2023 May 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $-2.69M | $-2.11M | $-1.43M | $-901.64K | $-111.52K | $135.56K | $243.09K | $342.00K | $423.72K | $-159.62K | $-100.85K | — |
| Total Equity (USD) | $-5.10M | $-4.52M | $-3.85M | $-3.32M | $-2.53M | $-2.28M | $-2.17M | $-2.07M | $-1.99M | $-24.55K | $6.15K | — |
| Metric | Q2 FY2026 May 31, 2026 10-Q ↗ | Q1 FY2026 Feb 28, 2026 10-Q ↗ | Q4 FY2025 Nov 30, 2025 10-K ↗ | Q3 FY2025 Aug 31, 2025 10-Q ↗ | Q2 FY2025 May 31, 2025 10-Q ↗ | Q1 FY2025 Feb 28, 2025 10-Q ↗ | Q4 FY2024 Nov 30, 2024 10-K ↗ | Q3 FY2024 Aug 31, 2024 10-Q ↗ | Q2 FY2024 May 31, 2024 10-Q ↗ | Q1 FY2024 Feb 29, 2024 10-Q ↗ | Q4 FY2023 Nov 30, 2023 10-K ↗ | Q2 FY2023 May 31, 2023 10-Q ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $88.93K | $139.81K | $-3.77K | $154.40K | $520.54K | $658.38K | $751.70K | $883.77K | $310.94K | $-30.70K | — | — |
| Operating Cash Flow (USD) | $-236.64K | $-109.50K | $-100.48K | $-107.91K | — | $-163.31K | $-59.00K | — | — | $-37.64K | — | — |
Secondary lens
Benchmark Lens
Compare BKHA against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare BKHA against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for BKHA
No bullish signals detected
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How BKHA compares to all companies
Peer Comparison
BKHA vs similar peers
Compare BKHA with peers
Stack BKHA against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 3 years · 12 quarters